2021. Cardiovascular repercussions of the use of SGLT2 inhibitors in patients with type 2 Diabetes Mellitus. Electronic Journal Collection Health. 13, 5 (May 2021), e6890. DOI:https://doi.org/10.25248/reas.e6890.2021.